Minerva Neurosciences, Inc. (NERV) stock

NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30

$2.30−0.08 (-3.36%)

Close on Nov 13, 2026Market cap $109.82MP/E –Yield –

Minerva Neurosciences gross margin

Gross margin is gross profit as a percentage of revenue.

Minerva Neurosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?